Published • loading... • Updated
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock Now Rated “Reduce” by Sell-Side Brokerages
Summary by thecerbatgem.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock Now Rated “Reduce” by Sell-Side Brokerages
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Free Report) has been assigned a consensus recommendation of “Reduce” from the eight ratings firms that are presently covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating and six have assigned a hold rating to the company. The average 1-year price objective […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
